Robert F. Hendrickson serves as Executive at CYTOGEN CORP, where they oversee executive responsibilities. Since joining the company, Robert F. Hendrickson has executed 6 insider transactions totaling $5.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 1, 2009 involved receiving (via award) 10,000 shares valued at $0.
Robert F. Hendrickson currently holds 80,345 shares of CYTOGEN CORP (CYTO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert F. Hendrickson has been a net buyer of CYTO stock. They have purchased $5.9K and sold $0 worth of shares.
Robert F. Hendrickson's most recent insider trade was on May 1, 2009, when they sold 10,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.58 |
| Discretionary |
| Nov 14, 2008 | UGNE | $5.9K | Purchase | 10,000 | $0.59 | Discretionary |
| May 8, 2008 | CYTO | $0 | Disposition | 10,000 | $N/A | Discretionary |
| May 8, 2008 | CYTO | $0 | Disposition | 3,000 | $N/A | Discretionary |
| Jun 13, 2007 | CYTO | $0 | Award | 10,000 | $N/A | Discretionary |